You are here

PwC to employers: Focus on all medical prices—and not just drug prices

Health plans expected to continue pushing for value-based payment arrangements.

Experts at PricewaterhouseCoopers’s Health Research Institute project that medical costs in the employer insurance market will increase by 6% next year. The good news: that falls within the range of 5.5%–7% that costs have been going up the last several years. Still the year-in, year-out cost increases in health care are not sustainable, says PwC. Efforts to rein in utilization have run their course, according to PwC’s health care experts, so employers need to tackle prices if they want to control their medical costs—and not just drug prices that have been the focus recently.

Source: PricewaterhouseCoopers

More Headlines

First Once-Daily, Nebulized Bronchodilator Available at End of 2018
AI Software Helps Physicians Prioritize Patients with Hemorrhagic Stroke or Intracranial Trauma
Empagliflozin Could Help Prevent Heart Disease and Heart Failure
Combination of Experimental Drug and Checkpoint Inhibitors Fight Tumor Cells
Zulresso May Alleviate Symptoms for Thousands of Women
Developed for Tumors Resistant to Other TKIs
New Drug Reduces Infection in Chemotherapy Patients
Daily Use of AHCC Supplement Could Support Immune System, Eliminate HPV
Unique Bio-Identical Hormone Therapy for Treatment of Hot Flashes